Dose-specific improvements in memory-rel
โ
A.V. Terry Jr.; J.J. Buccafusco; M.A. Prendergast
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 159 KB
The centrally acting nicotinic-cholinergic antagonist mecamylamine (mec) is well documented to produce amnestic effects in animals and humans. However, in certain circumstances the compound has enhanced performance of some memory-related tasks in animals and further investigation of this paradoxical